Logo Rosalind & Morris Goodman Cancer Institute

GCI Frontiers in Cancer Research Lecture Series

Sep 09, 2026


Rosalind and Morris Goodman Cancer Institute
Montreal, QC
Canada

Rosalind and Morris Goodman Cancer Institute

"SLAM family receptors as novel targets for anti-cancer immunotherapy" Dr. André Veillette, Director, Molecular Oncology Research Unit, Montreal Clinical Research Institute and Executive Director, Marathon of Hope Cancer Centres Network, Terry Fox Research Institute

Details

GCI Frontiers in Cancer Research Lecture Series

Sep 24, 2026


Rosalind and Morris Goodman Cancer Institute
Montreal, QC
Canada

Rosalind and Morris Goodman Cancer Institute

"Tissue protective effects of oncogenic p53 mutation in a mouse model" Yinon Ben-Neriah, MD-PhD, Professor of immunology and cancer research at the Hebrew University of Jerusalem

Details

GCI Frontiers in Cancer Research Lecture Series

Sep 30, 2026


Rosalind and Morris Goodman Cancer Institute
Montreal, QC
Canada

Rosalind and Morris Goodman Cancer Institute

"Mapping non-canonical neutrophils lineages in cancer" Dr. Daniela Cerezo-Wallis, Associate Research Scientist, Yale School of Medicine, USA

Details

GCI Frontiers in Cancer Research Lecture Series

Oct 14, 2026


Rosalind and Morris Goodman Cancer Institute
Montreal, QC
Canada

Rosalind and Morris Goodman Cancer Institute

"Identifying and targeting MYC protein-protein interactions" Linda Z. Penn, Ph.D., Canadian Research Chair in Molecular Oncology (Tier 1), UHN Director, Office of Research Trainees (ORT), Senior Scientist, Princess Margaret Cancer Centre, University Health Network,Professor, Department of Medical Biophysics, University of Toronto

Details